Raytheon Missiles & Defense, a business segment of RTX (NYSE: RTX), has been awarded a significant contract worth $1,151,111,454 for the production of Advanced Medium Range Air-to-Air Missiles (AMRAAM). The contract also includes the provision of AMRAAM Telemetry Systems, initial and field spares, as well as other production engineering support activities.

This contract encompasses Foreign Military Sales to several countries, including Bahrain, Belgium, Bulgaria, Canada, Finland, Hungary, Italy, Japan, Netherlands, Norway, Qatar, Saudi Arabia, Singapore, South Korea, Spain, Switzerland, Ukraine, and the United Kingdom. These sales account for approximately 39% of the total contract value.

The Air Force Life Cycle Management Center's Air Dominance Division Contracting Office, based at Eglin Air Force Base in Florida, serves as the contracting activity for this project. 

In after-hours, $RTX is currently trading at $97.83, up $0.13 (+0.13%).

LumiraDx Limited (Nasdaq: LMDX) soared over 45% in after-hours trading after receiving UK's MHRA (Medicines and Healthcare products Regulatory Agency) validation for the LumiraDx SARS-CoV-2 Ag Ultra and LumiraDx SARS-CoV2 Ag & RSV tests. 

The LumiraDx SARS-CoV-2 Ag Ultra test detects infection within 5 minutes, optimizing patient care. 

Simultaneously, the LumiraDx SARS-CoV2 Ag & RSV test differentiates between RSV and SARS-CoV-2 infections. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and RSV can be similar, and as RSV normally affects young infants, it is essential to correctly identify them to treat and manage patients accordingly. 

$LMDX is trading at $0.52 (+48.74%) in after-hours.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)